Free Trial

Leerink Partnrs Issues Negative Outlook for A Earnings

Agilent Technologies logo with Computer and Technology background

Agilent Technologies, Inc. (NYSE:A - Free Report) - Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Agilent Technologies in a research report issued on Tuesday, November 26th. Leerink Partnrs analyst P. Souda now expects that the medical research company will post earnings per share of $1.28 for the quarter, down from their prior forecast of $1.36. The consensus estimate for Agilent Technologies' current full-year earnings is $5.72 per share. Leerink Partnrs also issued estimates for Agilent Technologies' Q2 2025 earnings at $1.33 EPS, Q3 2025 earnings at $1.41 EPS, Q4 2025 earnings at $1.55 EPS, FY2025 earnings at $5.57 EPS and FY2026 earnings at $6.10 EPS.

Other analysts have also recently issued reports about the company. Stifel Nicolaus reissued a "buy" rating and set a $151.00 price target on shares of Agilent Technologies in a report on Monday, August 26th. Bank of America lifted their price target on Agilent Technologies from $140.00 to $147.00 and gave the stock a "neutral" rating in a report on Thursday, August 22nd. UBS Group raised their price objective on Agilent Technologies from $141.00 to $150.00 and gave the stock a "neutral" rating in a research note on Thursday, August 22nd. Sanford C. Bernstein lowered their price objective on Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating on the stock in a research note on Tuesday. Finally, Wells Fargo & Company assumed coverage on Agilent Technologies in a research note on Tuesday, August 27th. They set an "overweight" rating and a $157.00 price objective on the stock. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, Agilent Technologies has an average rating of "Hold" and an average target price of $143.40.

View Our Latest Research Report on Agilent Technologies

Agilent Technologies Stock Performance

Shares of A traded up $3.74 during mid-day trading on Wednesday, reaching $138.11. The company's stock had a trading volume of 2,336,028 shares, compared to its average volume of 1,730,408. Agilent Technologies has a 1-year low of $124.10 and a 1-year high of $155.35. The stock has a market cap of $39.68 billion, a P/E ratio of 31.25, a PEG ratio of 5.91 and a beta of 1.07. The business has a 50-day simple moving average of $137.72 and a two-hundred day simple moving average of $137.43. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, December 31st. This is an increase from Agilent Technologies's previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.72%. Agilent Technologies's payout ratio is presently 21.27%.

Insiders Place Their Bets

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company's stock, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Menard Financial Group LLC lifted its stake in shares of Agilent Technologies by 1.6% in the 2nd quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company's stock valued at $628,000 after purchasing an additional 77 shares during the period. McAdam LLC increased its position in Agilent Technologies by 3.1% in the 3rd quarter. McAdam LLC now owns 2,531 shares of the medical research company's stock valued at $376,000 after buying an additional 77 shares in the last quarter. Brown Brothers Harriman & Co. increased its position in Agilent Technologies by 13.5% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company's stock valued at $96,000 after buying an additional 77 shares in the last quarter. Global Retirement Partners LLC increased its position in Agilent Technologies by 3.2% in the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company's stock valued at $382,000 after buying an additional 79 shares in the last quarter. Finally, Rovin Capital UT ADV increased its position in Agilent Technologies by 1.6% in the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company's stock valued at $750,000 after buying an additional 81 shares in the last quarter.

About Agilent Technologies

(Get Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Stories

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Should you invest $1,000 in Agilent Technologies right now?

Before you consider Agilent Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.

While Agilent Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Small Caps, Financials & Bitcoin Lead the Rising Bull Market: Chris Rowe’s Top Picks
MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines